Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents | Zendy

Silvia Goñi Esarte | Zendy; Regina Juanbeltz | Zendy; Iván MartínezBaz | Zendy; Jesús Castilla | Zendy; Ramón San Miguel | Zendy; J.I. Herrero | Zendy; José Manuel Zozaya | Zendy

Open Access

Long-term changes on health-related quality of life in patients with chronic hepatitis C after viral clearance with direct-acting antiviral agents

Author(s) -

Silvia Goñi Esarte,

Regina Juanbeltz,

Iván MartínezBaz,

Jesús Castilla,

Ramón San Miguel,

J.I. Herrero,

José Manuel Zozaya

Publication year - 2019

Publication title -

revista española de enfermedades digestivas

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 0.331

H-Index - 38

eISSN - 2340-4167

pISSN - 1130-0108

DOI - 10.17235/reed.2019.6063/2018

Subject(s) - medicine , quality of life (healthcare) , visual analogue scale , observational study , depression (economics) , cirrhosis , anxiety , hepatitis c , prospective cohort study , gastroenterology , physical therapy , psychiatry , nursing , economics , macroeconomics

new direct-acting antivirals (DAAs) achieve high and sustained virological response (SVR) rates, although the long-term effect on patient health-related quality of life (HRQoL) is unknown. This study aimed to evaluate the impact of hepatitis C virus (HCV) clearance with DAAs on HRQoL after one year of follow-up.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research